Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. Senate. To amend the Public Health Service Act to streamline the review of biosimilar biological products. S. 5059. 119th Cong., 2nd sess., Introduced in Senate July 21, 2026. https://www.govinfo.gov/app/details/BILLS-119s5059is.
Congress, Senate (2026, July 21). To amend the Public Health Service Act to streamline the review of biosimilar biological products. (S. 5059 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s5059is.
United States, Congress, Senate. To amend the Public Health Service Act to streamline the review of biosimilar biological products. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s5059is. 119th Congress, S. 5059, Introduced in Senate 21 Jul. 2026.
S.5059 - 119th Congress (2025-2026): To amend the Public Health Service Act to streamline the review of biosimilar biological products., S.5059, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119s5059is.